Actively Recruiting
Stavanger University Hospital Inflammatory Bowel Disease Trial
Led by Helse Stavanger HF · Updated on 2025-05-16
700
Participants Needed
1
Research Sites
974 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined. Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.
CONDITIONS
Official Title
Stavanger University Hospital Inflammatory Bowel Disease Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Newly diagnosed with Inflammatory Bowel Disease (IBD)
You will not qualify if you...
- Previous IBD with specific treatment within the last 10 years
- Unable to provide consent
- Unable to follow the treatment protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
SUS
Stavanger, Norway
Actively Recruiting
Research Team
T
tore grimstad
CONTACT
L
lars aabakken
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here